logo-loader
AIM:TRLS

Trellus Health PLC

Receive alerts
Market:
AIM
Price
0.12 GBX
Day Change
-
Market Cap:
£516.14 k
52 weeks high
2.34
52 weeks low
0.04

In brief

Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver personalised care remotely via telemedicine.

The company is initially focused on Inflammatory Bowel Diseases ("IBD"), which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.